ARCHIVES Search | Login | Search Tips | FAQ | Pricing | About the Archive | Terms
ProQuest is no longer the archive provider for Chicago Tribune. Please visit their web site to view their new archive. If you have previously purchased articles, you may log in to view them. If you have an active article plan, you may log in and continue to use it.
Advanced Saved Help
Start a New Search
Buy Complete Document: AbstractAbstract Full Text Full Text
Chicago Tribune - Chicago, Ill.
Subjects: Hormones; Prescription drugs
Author: McCullough, Marie
Date: Sep 3, 1998
Start Page: 7
Section: NEWS
Abstract (Document Summary)

Recent research casts doubt on the conventional wisdom that hormones protect the heart. A four-year study, published in the Journal of the American Medical Association, found that in postmenopausal women who already had heart disease, taking estrogen and progestin did not prevent further heart attacks or death and increased the risk of blood clots.

The Food and Drug Administration this month approved Rhone- Poulenc-Rorer's CombiPatch, the first skin patch that combines estrogen and progestin. In May, the agency approved Solvay Pharmaceutical's Prometrium, the first pill containing an easily absorbed progesterone (a type of progestin) that is structurally identical to a woman's own progesterone. And in March, the FDA approved a new, lower dose of Solvay's Estratab, an estrogen pill, for prevention of osteoporosis.

While hormone options are multiplying, Premarin continues to be prescribed most often. Premarin, made by Wyeth-Ayerst Laboratories, is the oldest and most studied estrogen pill, and doctors have come to rely on it.

Buy Complete Document: AbstractAbstract Full Text Full Text

Most Viewed Articles  (Updated Daily)